Form 13-F position report

WEST PHARMACEUTICAL SERV INC

Reported by AMI ASSET MANAGEMENT CORP

WST CUSIP 955306105 Manager CIK 0001369702

Reported 141,556 shares, down 5,208 (3.5%) from the prior quarter.

Reported value -0.4%; share count -3.5% vs. the prior quarter.

Reduced
% of reported 13F value 3.01% This manager · Q3 2026
Shares 141,556 Quarter-end amount reported
Reported value $52,483,188 Fair value at quarter end
Consecutive quarters held 49 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 45121000
2022-03-31 39615000
2022-06-30 28803000
2022-09-30 22460000
2022-12-31 42853000
2023-03-31 62334630
2023-06-30 60721500
2023-09-30 60243553
2023-12-31 56170536
2024-03-31 65188351
2024-06-30 52678766
2024-09-30 55273243
2024-12-31 59832266
2025-03-31 38910960
2025-06-30 36168767
2025-09-30 42759688
2025-12-31 43757858
2026-03-31 38699122
2026-06-30 52688430
2026-09-30 52483188

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for WEST PHARMACEUTICAL SERV INC held by AMI ASSET MANAGEMENT CORP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 141,556 -5,208 (-3.5%) 3.01% $52,483,188 2026-10-20
Q2 2026 Reduced 146,764 -7,637 (-4.9%) 3.03% $52,688,430 2026-07-21
Q1 2026 Reduced 154,401 -4,638 (-2.9%) 2.47% $38,699,122 2026-04-23
Q4 2025 Reduced 159,039 -3,961 (-2.4%) 2.48% $43,757,858 2026-01-23
Q3 2025 Reduced 163,000 -2,305 (-1.4%) 2.39% $42,759,688 2025-10-16
Q2 2025 Reduced 165,305 -8,498 (-4.9%) 2.07% $36,168,767 2025-07-18
Q1 2025 Reduced 173,803 -8,857 (-4.8%) 2.28% $38,910,960 2025-04-23
Q4 2024 Reduced 182,660 -1,486 (-0.8%) 3.19% $59,832,266 2025-01-17
Q3 2024 Added 184,146 +24,218 (15.1%) 2.99% $55,273,243 2024-10-25
Q2 2024 Reduced 159,928 -4,810 (-2.9%) 2.84% $52,678,766 2024-07-25
Q1 2024 Added 164,738 +5,217 (3.3%) 3.33% $65,188,351 2024-04-19
Q4 2023 Reduced 159,521 -1,039 (-0.6%) 3.07% $56,170,536 2024-01-19
Q3 2023 Added 160,560 +1,799 (1.1%) 3.73% $60,243,553 2023-10-20
Q2 2023 Reduced 158,761 -21,152 (-11.8%) 3.61% $60,721,500 2023-07-25
Q1 2023 Reduced 179,913 -2,167 (-1.2%) 3.98% $62,334,630 2023-04-21
Q4 2022 Added 182,080 +90,810 (99.5%) 3.0% $42,853,000 2023-01-17
Q3 2022 Reduced 91,270 -3,988 (-4.2%) 1.64% $22,460,000 2022-10-24
Q2 2022 Reduced 95,258 -1,196 (-1.2%) 1.83% $28,803,000 2022-07-21
Q1 2022 Added 96,454 +249 (0.3%) 2.07% $39,615,000 2022-04-27
Q4 2021 Reduced 96,205 -2,958 (-3.0%) 2.18% $45,121,000 2022-01-20
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

946 managers reported WEST PHARMACEUTICAL SERV INC for Q3 2026.

Managers reporting WEST PHARMACEUTICAL SERV INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 6,702,494 +50,710 0.04% $2,485,016,461 9 qtrs
FMR LLC Added 5,988,538 +2,413,722 0.1% $2,220,310,302 33 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 4,605,822 -7,312 0.04% $1,707,654,565 3 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 4,130,135 +114,369 0.07% $1,531,288,853 3 qtrs
STATE STREET CORPORATION Reduced 3,329,438 -19,260 0.04% $1,234,422,433 54 qtrs
Artisan Partners Limited Partnership Reduced 2,007,802 -403,990 1.36% $744,422,275 37 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,936,541 +33,262 0.04% $715,179,497 54 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 1,738,854 -304,969 0.11% $644,697,665 54 qtrs
MORGAN STANLEY Reduced 1,574,426 -8,120 0.03% $583,735,245 54 qtrs
T Rowe Price Investment Management Inc Reduced 1,557,159 -247,860 0.41% $577,333,000 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 20, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
141,098
Shared
0
None
457

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.